PortfoliosLab logoPortfoliosLab logo
TFPM vs. GMED
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TFPM vs. GMED - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Triple Flag Precious Metals Corp (TFPM) and Globus Medical, Inc. (GMED). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TFPM achieves a -15.14% return, which is significantly lower than GMED's -10.54% return.


TFPM

1D
-1.44%
1M
0.36%
6M
-19.69%
YTD
-15.14%
1Y
19.91%
3Y*
29.68%
5Y*
10Y*

GMED

1D
1.92%
1M
-2.99%
6M
-17.32%
YTD
-10.54%
1Y
36.75%
3Y*
8.91%
5Y*
-0.63%
10Y*
12.07%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TFPM vs. GMED - Yearly Performance Comparison


2026 (YTD)20252024202320222021
TFPM
Triple Flag Precious Metals Corp
-15.14%123.03%14.60%-1.81%14.71%32.61%
GMED
Globus Medical, Inc.
-10.54%5.56%55.21%-28.25%2.87%-8.49%

Correlation

The correlation between TFPM and GMED is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.19

Correlation (3Y)
Calculated over the trailing 3-year period

0.14

Correlation (All Time)
Calculated using the full available price history since Sep 30, 2021

0.11

Fundamentals

Market Cap

TFPM:

$5.81B

GMED:

$10.53B

EPS

TFPM:

$1.50

GMED:

$4.28

PE Ratio

TFPM:

18.71

GMED:

18.23

PEG Ratio

TFPM:

0.14

GMED:

0.19

PS Ratio

TFPM:

12.84

GMED:

3.45

PB Ratio

TFPM:

2.70

GMED:

2.28

Total Revenue (TTM)

TFPM:

$453.24M

GMED:

$3.10B

Gross Profit (TTM)

TFPM:

$337.23M

GMED:

$1.58B

EBITDA (TTM)

TFPM:

$354.95M

GMED:

$803.34M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TFPM vs. GMED — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TFPM
TFPM Risk / Return Rank: 5959
Overall Rank
TFPM Sharpe Ratio Rank: 6262
Sharpe Ratio Rank
TFPM Sortino Ratio Rank: 5757
Sortino Ratio Rank
TFPM Omega Ratio Rank: 5656
Omega Ratio Rank
TFPM Calmar Ratio Rank: 6060
Calmar Ratio Rank
TFPM Martin Ratio Rank: 6161
Martin Ratio Rank

GMED
GMED Risk / Return Rank: 7373
Overall Rank
GMED Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
GMED Sortino Ratio Rank: 7575
Sortino Ratio Rank
GMED Omega Ratio Rank: 7272
Omega Ratio Rank
GMED Calmar Ratio Rank: 7575
Calmar Ratio Rank
GMED Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TFPM vs. GMED - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Triple Flag Precious Metals Corp (TFPM) and Globus Medical, Inc. (GMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TFPMGMEDDifference
Sharpe ratioReturn per unit of total volatility

-0.23

Sortino ratioReturn per unit of downside risk

-0.84

Omega ratioGain probability vs. loss probability

1.12

1.21

-0.09

Calmar ratioReturn relative to maximum drawdown

0.62

1.60

-0.98

Martin ratioReturn relative to average drawdown

1.52

3.87

-2.34

TFPM vs. GMED - Sharpe Ratio Comparison

The current TFPM Sharpe Ratio is 0.49, which is lower than the GMED Sharpe Ratio of 0.71. The chart below compares the historical Sharpe Ratios of TFPM and GMED, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TFPM vs. GMED - Drawdown Comparison

The maximum TFPM drawdown since its inception was -36.48%, smaller than the maximum GMED drawdown of -47.91%. Use the drawdown chart below to compare losses from any high point for TFPM and GMED.


Loading charts...

Drawdown Indicators


TFPMGMEDDifference

Max Drawdown

Largest peak-to-trough decline

-36.48%

-47.91%

+11.43%

Max Drawdown (1Y)

Largest decline over 1 year

-34.87%

-22.10%

-12.77%

Max Drawdown (3Y)

Largest decline over 3 years

-34.87%

-44.40%

+9.53%

Max Drawdown (5Y)

Largest decline over 5 years

-47.91%

Max Drawdown (10Y)

Largest decline over 10 years

-47.91%

Current Drawdown

Current decline from peak

-31.84%

-19.32%

-12.52%

Average Drawdown

Average peak-to-trough decline

-13.65%

-15.33%

+1.68%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.19%

9.13%

+5.06%

Volatility

TFPM vs. GMED - Volatility Comparison

Triple Flag Precious Metals Corp (TFPM) has a higher volatility of 15.53% compared to Globus Medical, Inc. (GMED) at 13.69%. This indicates that TFPM's price experiences larger fluctuations and is considered to be riskier than GMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TFPMGMEDDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.53%

13.69%

+1.84%

Volatility (6M)

Calculated over the trailing 6-month period

35.31%

25.33%

+9.98%

Volatility (1Y)

Calculated over the trailing 1-year period

44.54%

49.46%

-4.92%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

37.68%

38.27%

-0.59%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

37.68%

35.68%

+2.00%

Dividends

TFPM vs. GMED - Dividend Comparison

TFPM's dividend yield for the trailing twelve months is around 0.82%, while GMED has not paid dividends to shareholders.


PositionTTM20252024202320222021
GMED
Globus Medical, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%
TFPM
Triple Flag Precious Metals Corp
0.82%0.68%1.43%1.54%1.07%0.39%

Financials

TFPM vs. GMED - Financials Comparison

This section allows you to compare key financial metrics between Triple Flag Precious Metals Corp and Globus Medical, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
144.96M
759.85M
(TFPM) Total Revenue
(GMED) Total Revenue
Values in USD except per share items

TFPM vs. GMED - Profitability Comparison

The chart below illustrates the profitability comparison between Triple Flag Precious Metals Corp and Globus Medical, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
72.0%
0
Portfolio components
TFPM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Triple Flag Precious Metals Corp reported a gross profit of 104.35M and revenue of 144.96M. Therefore, the gross margin over that period was 72.0%.

GMED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported a gross profit of 0.00 and revenue of 759.85M. Therefore, the gross margin over that period was 0.0%.

TFPM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Triple Flag Precious Metals Corp reported an operating income of 97.00M and revenue of 144.96M, resulting in an operating margin of 66.9%.

GMED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported an operating income of 150.39M and revenue of 759.85M, resulting in an operating margin of 19.8%.

TFPM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Triple Flag Precious Metals Corp reported a net income of 115.31M and revenue of 144.96M, resulting in a net margin of 79.6%.

GMED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported a net income of 124.30M and revenue of 759.85M, resulting in a net margin of 16.4%.


Frequently Asked Questions


TFPM and GMED have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TFPM has higher volatility (15.53%) compared to GMED (13.69%). In terms of maximum drawdown, TFPM dropped -36.48% vs GMED's -47.91%.

GMED currently has the higher Sharpe Ratio (0.71 vs 0.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TFPM and GMED

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer